Should drug users and their families be trained in basic resuscitation methods?

Should drug users and their families be trained in basic resuscitation methods, and be allowed to administer interim emergency naloxone to prevent overdose deaths whilst awaiting emergency medical help? If so why are the drug regulators so resistant to implementing these obvious harm reduction measures?

Professor John Strang, Director of National Addiction Centre, with over 25 years experience as a clinician, researcher and formulator of policy, presents a talk on these controversial issues in his lecture as part of the University of Hertfordshire’s Healthcare Forum Series.

Professor Strang will also discuss why those involved with the misuse of drugs are ten times more likely to die than non-drug users of the same age. This excess mortality is mostly a result of overdose deaths of which the vast majority are accidental.

The lecture will be held in the Lindop Building, College Lane campus, University of Hertfordshire on Wednesday 9 June. It will commence at 7.00pm and be preceded by a light buffet supper at 6.30pm. There is a £5.00 charge per person for the event.

For further information please contact Julie Huckle at the University of Hertfordshire on 01707 284004 or email [email protected] , http://www.herts.ac.uk

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 receptor agonists show promise in treating substance use disorders